IA
CAPR icon

IFP Advisors’s Capricor Therapeutics CAPR Stock Holding History

IFP Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.83K Buy
+325
New +$9.85K ﹤0.01% 3536
2025
Q2 		– Hold
0
– – – 4676

Other funds holding CAPR

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

IFP Advisors's CAPR Position: Q2 2026 in Review

IFP Advisors opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 325 shares worth $7.83K. The stake represents ﹤0.01% of the portfolio and ranks #3536 among its holdings.

11 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • IFP Advisors held 325 shares of Capricor Therapeutics worth $7.83K as of Q2 2026.
  • Capricor Therapeutics was a new IFP Advisors position in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3536 holding.
  • 11 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.